WorldFuture and humanity

Data from registrational study of Sugemalimab cell lung cancer published
cell lung cancer

Data from registrational study of Sugemalimab cell lung cancer published

SUZHOU, China, Jan. 15, 2022– CStone Pharmaceuticals (HKEX: 2616), a leading biopharmaceutical company, today announced that the registrational clinical data from sugemalimab (the GEMSTONE-301 study) in stage III non-small cell lung cancer (NSCLC) were published in the world-leading clinical oncology journal, The Lancet Oncology.  Sugemalimab as a consolidation therapy demonstrated
3 min read
UOB Acquiring Citigroup’s Consumer Business in Indonesia, Malaysia, Thailand and Vietnam
acquisition

UOB Acquiring Citigroup’s Consumer Business in Indonesia, Malaysia, Thailand and Vietnam

Singapore, 14 January 2022 – United Overseas Bank Limited (UOB)’s subsidiaries have entered into agreements to acquire Citigroup’s consumer banking businesses comprising its unsecured and secured lending portfolios, wealth management and retail deposit businesses (the Consumer Business) in Indonesia, Malaysia, Thailand and Vietnam (the Proposed Acquisition). As part of
3 min read